• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪源性干细胞疗法联合富血小板血浆治疗距骨缺血性坏死

Adipose-Derived Stem Cell Therapy Combined With Platelet-Rich Plasma for the Treatment of Avascular Necrosis of the Talus.

作者信息

Sousa Rui, Babulal Jaime, Amado Paulo

机构信息

Orthopaedics and Traumatology Department, Unidade Local de Saúde de Viseu Dão-Lafões, Viseu, PRT.

Orthopaedics and Traumatology Department, Unidade Local de Saúde do Médio Ave, Vila Nova de Famalicão, PRT.

出版信息

Cureus. 2025 Jan 17;17(1):e77578. doi: 10.7759/cureus.77578. eCollection 2025 Jan.

DOI:10.7759/cureus.77578
PMID:39958013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11830220/
Abstract

Avascular necrosis (AVN) is characterized by compromised blood supply to bone tissue, often resulting in significant pain and functional impairment. Conservative treatment options for early-stage AVN of the talus are scarce, with non-weight-bearing protocols and hyperbaric oxygen therapy showing limited efficacy. This report presents a potential novel approach to managing non-traumatic AVN of the talus using a combination of adipose-derived stromal vascular fraction (SVF) and platelet-rich plasma (PRP). A 60-year-old male presented with progressive right ankle pain of a two-year evolution. Magnetic resonance imaging (MRI) revealed stage II AVN of the talus with extensive bone infarctions occupying almost all of its volume but with no collapse. A single injection of SVF and PRP was performed after diagnostic arthroscopy, followed by a tailored rehabilitation protocol. The patient experienced significant pain relief, with no further need for analgesics, and was able to return to non-impact sports. At the 18-month follow-up, functional scores showed significant improvement, and MRI showed stable AVN with no evidence of collapse. This report highlights SVF and PRP as a potential effective conservative option for non-traumatic talar AVN.

摘要

缺血性坏死(AVN)的特征是骨组织血液供应受损,常导致严重疼痛和功能障碍。距骨早期AVN的保守治疗选择稀缺,非负重方案和高压氧治疗的疗效有限。本报告介绍了一种使用脂肪来源的基质血管成分(SVF)和富血小板血浆(PRP)联合治疗距骨非创伤性AVN的潜在新方法。一名60岁男性出现进行性右踝关节疼痛,病程两年。磁共振成像(MRI)显示距骨II期AVN,广泛的骨梗死几乎占据其全部体积,但无塌陷。在诊断性关节镜检查后进行了一次SVF和PRP注射,随后采用了定制的康复方案。患者疼痛明显缓解,无需再使用镇痛药,并能够恢复非冲击性运动。在18个月的随访中,功能评分显示有显著改善,MRI显示AVN稳定,无塌陷迹象。本报告强调SVF和PRP作为非创伤性距骨AVN的一种潜在有效保守治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2e/11830220/ab0c212062e6/cureus-0017-00000077578-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2e/11830220/9ce766d4e90b/cureus-0017-00000077578-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2e/11830220/9005ddc778a8/cureus-0017-00000077578-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2e/11830220/ab0c212062e6/cureus-0017-00000077578-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2e/11830220/9ce766d4e90b/cureus-0017-00000077578-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2e/11830220/9005ddc778a8/cureus-0017-00000077578-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2e/11830220/ab0c212062e6/cureus-0017-00000077578-i03.jpg

相似文献

1
Adipose-Derived Stem Cell Therapy Combined With Platelet-Rich Plasma for the Treatment of Avascular Necrosis of the Talus.脂肪源性干细胞疗法联合富血小板血浆治疗距骨缺血性坏死
Cureus. 2025 Jan 17;17(1):e77578. doi: 10.7759/cureus.77578. eCollection 2025 Jan.
2
Complete resolution of avascular necrosis of the human femoral head treated with adipose tissue-derived stem cells and platelet-rich plasma.采用脂肪组织来源干细胞和富血小板血浆治疗的人类股骨头缺血性坏死完全消退。
J Int Med Res. 2014 Dec;42(6):1353-62. doi: 10.1177/0300060514546940. Epub 2014 Oct 3.
3
Treatment of AVN Using Autologous BM Stem Cells and Activated Platelet-Derived Growth Factor Concentrates.使用自体骨髓干细胞和活化血小板衍生生长因子浓缩物治疗股骨头缺血性坏死。
J Stem Cells. 2016;11(3):135-148.
4
Arthroscopic ankle fusion for avascular necrosis of the talus.关节镜下距骨缺血性坏死踝关节融合术
Foot Ankle Int. 2015 May;36(5):591-7. doi: 10.1177/1071100714565901. Epub 2015 Jan 20.
5
Intratendinous adipose-derived stromal vascular fraction (SVF) injection provides a safe, efficacious treatment for Achilles tendinopathy: results of a randomized controlled clinical trial at a 6-month follow-up.肌腱内脂肪来源的基质血管成分(SVF)注射为跟腱病提供了一种安全、有效的治疗方法:6 个月随访的随机对照临床试验结果。
Knee Surg Sports Traumatol Arthrosc. 2018 Jul;26(7):2000-2010. doi: 10.1007/s00167-017-4479-9. Epub 2017 Mar 1.
6
Effectiveness of Stromal Vascular Fraction (SVF) and Platelet-Rich Plasma (PRP) in Patients With Knee Osteoarthritis: Protocol for a Phase 3, Prospective, Randomized, Controlled, Multicenter Study (SPOST Study).基质血管成分(SVF)和富血小板血浆(PRP)治疗膝关节骨关节炎患者的有效性:一项3期前瞻性随机对照多中心研究方案(SPOST研究)
JMIR Res Protoc. 2025 Apr 8;14:e62659. doi: 10.2196/62659.
7
Medial Femoral Condyle Periosteal Free Flap for the Treatment of Talus Avascular Necrosis.股骨干骺端骨膜游离皮瓣治疗距骨缺血性坏死。
Foot Ankle Int. 2020 Jun;41(6):728-734. doi: 10.1177/1071100720917158. Epub 2020 Apr 24.
8
Avascular Necrosis of the Talus: Diagnosis, Treatment, and Modern Reconstructive Options.距骨骨坏死:诊断、治疗和现代重建选择。
Medicina (Kaunas). 2024 Oct 15;60(10):1692. doi: 10.3390/medicina60101692.
9
The prognostic value of the hawkins sign and diagnostic value of MRI after talar neck fractures.距骨颈骨折后霍金斯征的预后价值及MRI的诊断价值
Foot Ankle Int. 2014 Dec;35(12):1255-61. doi: 10.1177/1071100714547219. Epub 2014 Aug 12.
10
Management Options in Avascular Necrosis of Talus.距骨缺血性坏死的治疗选择
Indian J Orthop. 2018 May-Jun;52(3):284-296. doi: 10.4103/ortho.IJOrtho_608_17.

本文引用的文献

1
Adipose tissue-derived injectable products combined with platelet-rich plasma for the treatment of osteoarthritis: the promising preclinical results are not confirmed by the clinical evidence.脂肪组织衍生的可注射产品联合富血小板血浆治疗骨关节炎:有前景的临床前结果未得到临床证据的证实。
EFORT Open Rev. 2024 Nov 8;9(11):1023-1033. doi: 10.1530/EOR-24-0050.
2
Avascular Necrosis of the Talus: Diagnosis, Treatment, and Modern Reconstructive Options.距骨骨坏死:诊断、治疗和现代重建选择。
Medicina (Kaunas). 2024 Oct 15;60(10):1692. doi: 10.3390/medicina60101692.
3
Minimally Invasive Treatment of Trapeziometacarpal Osteoarthritis: Results of a Blinded Randomized Controlled Trial.
掌指关节骨关节炎的微创治疗:一项盲法随机对照试验的结果。
Plast Reconstr Surg. 2023 Dec 1;152(6):1277-1285. doi: 10.1097/PRS.0000000000010516. Epub 2023 Apr 11.
4
The intra-articular injection of adipose-derived stem cells decreases pain and reduces inflammation in knee osteoarthritis, with or without the addition of platelet-rich plasma also improves functionality.关节内注射脂肪来源的干细胞可减轻膝骨关节炎的疼痛并减少炎症,无论是否添加富含血小板的血浆,均可改善功能。
J Tissue Eng Regen Med. 2022 Oct;16(10):900-912. doi: 10.1002/term.3337. Epub 2022 Jul 7.
5
Autologous Microfragmented Adipose Tissue for the Treatment of Knee Osteoarthritis: Real-World Data at Two Years Follow-Up.自体微片段脂肪组织治疗膝关节骨关节炎:两年随访的真实世界数据
J Clin Med. 2022 Feb 25;11(5):1268. doi: 10.3390/jcm11051268.
6
Comparison of the Effect of MFAT and MFAT + PRP on Treatment of Hip Osteoarthritis: An Observational, Intention-to-Treat Study at One Year.脂肪源性基质血管成分(MFAT)与MFAT联合富血小板血浆(PRP)治疗髋骨关节炎的疗效比较:一项为期一年的观察性意向性治疗研究
J Clin Med. 2022 Feb 17;11(4):1056. doi: 10.3390/jcm11041056.
7
Intra-Articular Injection of Autologous Microfat and Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Double-Blind Randomized Comparative Study.关节内注射自体微脂肪和富含血小板血浆治疗膝骨关节炎:一项双盲随机对照研究。
Arthroscopy. 2021 Oct;37(10):3125-3137.e3. doi: 10.1016/j.arthro.2021.03.074. Epub 2021 Apr 20.
8
Patient-Centered Outcomes of Microfragmented Adipose Tissue Treatments of Knee Osteoarthritis: An Observational, Intention-to-Treat Study at Twelve Months.膝关节骨关节炎微片段脂肪组织治疗以患者为中心的结局:一项为期十二个月的观察性意向性治疗研究。
Stem Cells Int. 2020 Aug 4;2020:8881405. doi: 10.1155/2020/8881405. eCollection 2020.
9
Limited evidence for adipose-derived stem cell therapy on the treatment of osteoarthritis.脂肪来源干细胞治疗骨关节炎的有限证据。
Knee Surg Sports Traumatol Arthrosc. 2018 Nov;26(11):3499-3507. doi: 10.1007/s00167-018-4955-x. Epub 2018 Apr 30.
10
Stem cell therapy in early post-traumatic talus osteonecrosis.早期创伤性距骨骨坏死的干细胞治疗。
Int Orthop. 2018 Dec;42(12):2949-2956. doi: 10.1007/s00264-017-3716-7. Epub 2018 Jan 5.